TTM
$5.00B
YoY change
+11.1%
5Y CAGR
—
Peak year (2025)
$3.74B
Cumulative EBITDA
$37.49B
EBITDA history chart for Cencora (COR) from 1994 to 2025
Latest: $3.74B
EBITDA growth chart for Cencora (COR) from 1994 to 2025
Latest: +11.1%
EBITDA history table for Cencora (COR) from 1994 to 2025
| 2025 | $3.74B | +11.1% | +$372.00M | ||
| 2024 | $3.36B | -1.3% | −$44.55M | ||
| 2023 | $3.41B | +9.5% | +$295.90M | ||
| 2022 | $3.11B | +7.0% | +$203.41M | ||
| 2021 | $2.91B | -161.5% | +$7.64B | ||
| 2020 | −$4.73B | -386.7% | −$6.38B | ||
| 2019 | $1.65B | -11.5% | −$215.58M | ||
| 2018 | $1.87B | +25.3% | +$376.85M | ||
| 2017 | $1.49B | -22.4% | −$430.44M | ||
| 2016 | $1.92B | +204.4% | +$1.29B | ||
| 2015 | $630.77M | -32.8% | −$308.42M | ||
| 2014 | $939.18M | -11.8% | −$126.15M | ||
| 2013 | $1.07B | -24.0% | −$337.01M | ||
| 2012 | $1.40B | +5.4% | +$71.57M | ||
| 2011 | $1.33B | +10.7% | +$128.99M | ||
| 2010 | $1.20B | +22.9% | +$224.18M | ||
| 2009 | $977.61M | +5.3% | +$48.80M | ||
| 2008 | $928.80M | -3.3% | −$31.63M | ||
| 2007 | $960.43M | +13.5% | +$114.29M | ||
| 2006 | $846.14M | +37.2% | +$229.21M | ||
| 2005 | $616.93M | -36.4% | −$353.76M | ||
| 2004 | $970.69M | +0.3% | +$2.92M | ||
| 2003 | $967.77M | +16.1% | +$134.28M | ||
| 2002 | $833.49M | +171.0% | +$525.90M | ||
| 2001 | $307.59M | +41.9% | +$90.86M | ||
| 2000 | $216.73M | +3.8% | +$8.03M | ||
| 1999 | $208.70M | +7.1% | +$13.80M | ||
| 1998 | $194.90M | +45.6% | +$61.00M | ||
| 1997 | $133.90M | +22.3% | +$24.40M | ||
| 1996 | $109.50M | +1.5% | +$1.60M | ||
| 1995 | $107.90M | -60.4% | −$164.50M | ||
| 1994 | $272.40M | — | — |
- 2025$3.74B+11.1%
- 2024$3.36B-1.3%
- 2023$3.41B+9.5%
- 2022$3.11B+7.0%
- 2021$2.91B-161.5%
- 2020−$4.73B-386.7%
- 2019$1.65B-11.5%
- 2018$1.87B+25.3%
- 2017$1.49B-22.4%
- 2016$1.92B+204.4%
- 2015$630.77M-32.8%
- 2014$939.18M-11.8%
- 2013$1.07B-24.0%
- 2012$1.40B+5.4%
- 2011$1.33B+10.7%
- 2010$1.20B+22.9%
- 2009$977.61M+5.3%
- 2008$928.80M-3.3%
- 2007$960.43M+13.5%
- 2006$846.14M+37.2%
- 2005$616.93M-36.4%
- 2004$970.69M+0.3%
- 2003$967.77M+16.1%
- 2002$833.49M+171.0%
- 2001$307.59M+41.9%
- 2000$216.73M+3.8%
- 1999$208.70M+7.1%
- 1998$194.90M+45.6%
- 1997$133.90M+22.3%
- 1996$109.50M+1.5%
- 1995$107.90M-60.4%
- 1994$272.40M—
EBITDA values are taken from Cencora's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Cencora (COR)
According to Cencora's latest reported financial statements, the company's current EBITDA (TTM) is $5.00B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Cencora (COR) reported EBITDA of $3.74B – grew 11.1% year-over-year.
Cencora EBITDA has grown on net over the period, with a +19.5% compound annual growth rate over 2015–2025 (10 years).
2025 marks the peak EBITDA at $3.74B, with the historical low of −$4.73B recorded in 2020.
Cencora EBITDA by Year
Cencora EBITDA 2025: $3.74B
In 2025, Cencora reported EBITDA of $3.74B, grew 11.1% from 2024. This figure represents the highest annual value in the available history.
Cencora EBITDA 2024: $3.36B
Cencora EBITDA in 2024 was $3.36B, edged down 1.3% below 2023.
Cencora EBITDA 2023: $3.41B
2023's EBITDA for Cencora came in at $3.41B, grew 9.5% from 2022.
Cencora EBITDA 2022: $3.11B
Cencora posted EBITDA of $3.11B in 2022, grew 7.0% from 2021.
Cencora EBITDA 2021: $2.91B
Cencora EBITDA in 2021 was $2.91B.
See more financial history for Cencora (COR).
Sector peers by EBITDA
Healthcare peers of Cencora (COR), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Cencora (COR) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation